SynthesisVaccine2018
Systematic review of the incremental costs of interventions that increase immunization coverage.
Synthesis in Vaccine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Pooled it
- Pooled it
- Systematic review of the costs and effectiveness of interventions to increase infant vaccination coverage in low- and middle-income countries.BMC health services research · 2019Pooled it
- Costs of Interventions to Increase Vaccination Coverage Among Children in the United States: A Systematic Review.Academic pediatricsPooled it
- Factors contributing to incomplete vaccination among children aged 12 to 59 months in Mbale city, Eastern Uganda: a caregivers and health workers' perspective.BMC pediatrics · 2026Article
- Modeling the effects of improving varicella vaccination coverage on clinical and economic outcomes in Peru.Human vaccines & immunotherapeutics · 2025Article
- Scoping Review of Current Costing Literature on Interventions to Reach Zero-Dose Children in Low- and Middle-Income Countries.Vaccines · 2024Article
- Health impact and cost-effectiveness of expanding routine immunization coverage in India through Intensified Mission Indradhanush.Health policy and planning · 2024Article
- Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries.BMJ global health · 2023Article
- To EHB 1638 or Not to EHB 1638? For Immunization Policymakers, That Is the Question.American journal of public health · 2023Article
- Achieving immunization agenda 2030 coverage targets for 14 pathogens: Projected product and immunization delivery costs for 194 Countries, 2021-2030.Vaccine: X · 2023Article
- Reframing Optimal Control Problems for Infectious Disease Management in Low-Income Countries.Bulletin of mathematical biology · 2023Article
- Use of community engagement interventions to improve child immunisation in low- and middle-income countries: A systematic review and meta-analysis.Campbell systematic reviews · 2022Review
- Cost-effectiveness of routine versus indicated antibiotic therapy in the management of severe wasting in children.Cost effectiveness and resource allocation : C/E · 2022Article
- Unmet need for COVID-19 vaccination coverage in Kenya.Vaccine · 2022Article
- Polio health economics: assessing the benefits and costs of polio, non-polio, and integrated activities of the Global Polio Eradication Initiative.Gates open research · 2022Article
- The incremental cost of improving immunization coverage in India through the Intensified Mission Indradhanush programme.Health policy and planning · 2021Article
- A data-driven framework for introducing predictive analytics into expanded program on immunization in Pakistan.Wiener klinische Wochenschrift · 2021Article
- An Updated Economic Analysis of the Global Polio Eradication Initiative.Risk analysis : an official publication of the Society for Risk Analysis · 2021Article
- Health and Economic Outcomes Associated with Polio Vaccine Policy Options: 2019-2029.Risk analysis : an official publication of the Society for Risk Analysis · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Achieving and maintaining high vaccination coverage requires investments, but the costs and effectiveness of interventions to increase coverage remain poorly characterized. We conducted a systematic review of the literature to identify peer-reviewed studies published in English that reported interventions aimed at increasing immunization coverage and the associated costs and effectiveness of the interventions. We found limited information in the literature, with many studies reporting effectiveness estimates, but not providing cost information. Using the available data, we developed a cost function to support future programmatic decisions about investments in interventions to increase immunization coverage for relatively low and high-income countries. The cost function estimates the non-vaccine cost per dose of interventions to increase absolute immunization coverage by one percent, through either campaigns or routine immunization. The cost per dose per percent increase in absolute coverage increased with higher baseline coverage, demonstrating increasing incremental costs required to reach higher coverage levels. Future studies should evaluate the performance of the cost function and add to the database of available evidence to better characterize heterogeneity in costs and generalizability of the cost function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.